Considering the increased oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) in the bone marrow of the mesothelin-high group, we postulated that mesothelin modulates metabolism in AML. This evidence concerns the gene MSLN and acute myeloid leukemia.